Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: China Clear all

1,153 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20031
20042
20054
20067
200716
200826
200916
201015
201122
201221
201332
201428
201544
201637
201747
201863
2019101
202082
202196
202298
202383
2024117
2025103
202680

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status454
Completed262
Recruiting259
Not yet recruiting65
Active, not recruiting46
Terminated28
Withdrawn24
Enrolling by invitation8
Suspended6
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University152
Shanghai Zhongshan Hospital45
Eastern Hepatobiliary Surgery Hospital44
Fudan University38
Second Affiliated Hospital of Guangzhou Medical University27
Zhongda Hospital25
Guangxi Medical University24
Peking Union Medical College Hospital22
Second Affiliated Hospital, Zhejiang University, School of Medicine22
Tongji Hospital22

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular1,153
Liver Neoplasms90
Recurrence35
Colorectal Neoplasms24
Stomach Neoplasms24
Carcinoma, Non-Small-Cell Lung21
Cholangiocarcinoma18
Hepatitis B18
Neoplasms17
Pancreatic Neoplasms15

Trials

Showing 1 to 25 of 1,153. Each trial links to its page on Pharma Observatory.

1,053 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.